Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor‐based morphometry

A key question in designing MRI‐based clinical trials is how the main magnetic field strength of the scanner affects the power to detect disease effects. In 110 subjects scanned longitudinally at both 3.0 and 1.5 T, including 24 patients with Alzheimer's Disease (AD) [74.8 ± 9.2 years, MMSE: 22...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ho, April J., Hua, Xue, Lee, Suh, Leow, Alex D., Yanovsky, Igor, Gutman, Boris, Dinov, Ivo D., Leporé, Natasha, Stein, Jason L., Toga, Arthur W., Jack, Clifford R., Bernstein, Matt A., Reiman, Eric M., Harvey, Danielle J., Kornak, John, Schuff, Norbert, Alexander, Gene E., Weiner, Michael W., Thompson, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2009
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875376/
https://ncbi.nlm.nih.gov/pubmed/19780044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.20882
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares